Processa Pharmaceuticals, Inc. (PCSA)

Market price: $1.85

6 methods not shown

• EV / EBITDA: EBITDA is non-positive — an EBITDA multiple yields no meaningful enterprise value (loss-making at the EBITDA line)
• EV / Revenue: revenue unavailable — cannot form EV / Revenue
• EV / Gross Profit: no multiple band available for EV / Gross Profit — supplied with market data (peer comps / own history)
• P / E: diluted EPS is non-positive — P/E is not meaningful for a loss-making period
• P / B: book value per share is non-positive (negative common equity) — P/B is not meaningful
• DCF (FCFF): DCF input(s) unavailable (capex, revenue_cagr) — cannot build FCFF

We can't show a valuation range for this company yet — we have its financial data, but not a peer group we can stand behind to compare it against, and the methods that apply here price a company against comparable companies.